Summary: In this study we describe protein binding assays for 25-hydroxy, 24,25-dihydroxy and 1,25-dihydroxy metabolites of vitamin D in 6 ml of plasma. The procedure involves methanol/methylene chloride extraction of plasma followed by separation and purification of mono-and dihydroxylated vitamin D metabolites on two LH 20 columns with different elution solvents. The separation of dihydroxylated vitamin D metabolites is carried out by high performance liquid chromatography (HPLC). 
Introduction
It is now well documented that the physiological effects of vitamin D are exerted by hydroxylated metabolites rather than the parent vitamin itself. Vitamin D 3 is produced photochemically in the skin from 7-dehydrocholesterol or absorbed from the diet and initially hydroxylated in the liver to 25-hydroxy-cholecalciferol, the major circulating form of vitamin D 3 (1) . This metabolite can serve in the kidney as the substrate for further hydroxylation to 24,25-dihydroxy- (2) , to 1,25-dihydroxy-(3) and to 1,24,25-trihydroxy-cholecalciferol (4) . Of these metabolites, 1,25-dihydroxycholecalciferol on the basis of its mechanism of action, must be regarded as a hormone which plays a central role in the maintenance of calcium and phosphorus homeostatis, whereas the physiological importance of 24,25-dihydroxy-and 1,24,25-trihydroxycholecalciferol still has to be clarified. Quantitative methods for the determination of 25-hydroxy, 24,25-dihydroxy and 1,25-dihydroxy metabolites of vitamin D have been described (tab. 1).
We have developed a practicable method for simultaneous measurement of these vitamin D metabolites in a single serum sample.
Materials and Methods

Materials [l,2(n)-
The commercial vitamin D$ derivatives were purified by water cooled Sephadex LH 20 columns (1.5 X 50.0 cm, Pharmacia Fine Chemicals, Uppsala, Sweden), elution solvent: n-hexane/ chloroform/methanol (90 ml + 10 ml + 10 ml) followed by HPLC (Laboratory Data Control, Florida, USA), utilising LiChrosorb SI 100 (0.4 X 30.0 cm, ), elution solvent: dichloromethane/methanol (98 ml + 2 ml). The organic solvents and LiChrosorb Si 100 were obtained from Merck-Darmstadt. 
Björkhem et &L (16)
Hill et al·. (17) etal. (18) light and provided ad libitum with a vitamin D-deficient purified soy protein diet and deionized water, until sacrifice by decapitation at 4-5 weeks. The cytosol was frozen in an acetone dry ice bath and stored under N 2 gas at -80 °C until use. The protein concentration of the cytosol used in the assay was 0.9 g/1.
Extraction of plasma (Scheme 1) 3 H]l,25-dihydroxycholecalciferol (1500 counts/min, specific activity 4.07 PBq/mol) in ethanol were added. The sample was divided into two 3 mi portions. Each portion was placed in a 20 ml glass centrifuge tube in an ice bath and the sample was extracted with 3 voL of cold methanol/methylene chloride (200 ml +100 ml) per voL of plasma and vortexed for 3 min. One voL of cold methylene chloride was added, the sample was vortexed for 3 min and then centrifuged at 1400^ for 15 min at 4 °C (MSE, Fisons, Colora, D sseldorf). The extraction was repeated with 2 vol. of cold methylene chloride. All organic phases of the two 3 ml portions were combined, placed in a 100 ml separatory funnel, washed twice with an equal volume of phosphate buffer (0.05 mol/1, .pH 8.5) and evaporated to dry ness on a rotary evaporator under reduced pressure.
Gel chromatography
The methanol/methylene chloride plasma extracts were solubilized in 500 ìÀ of H-hexane/chloroform/methanol (90 ml + 10 ml + 10 ml) and chromatographed on a 0.9 X 10.0 cm Sephadex LH 20 column equilibrated with the same solvent system. The tube was re washed twice with 100 ìÀ of the solvent. The first 5 ml of elution was discarded, the next 10 ml was collected as the 25- The assays were carried out in a shaking water bath at 25 °C for 2 h and then the tubes were immersed in an ice water bath. 0.5 ml of 10 g/1 charcoal (Norit A, Serva, Heidelberg) in Trisbuffer was added to each assay tube, which was then vortexed vigorously for one minute. The tubes were centrifuged at 1400 £ for 20 min at 4 °C, and 1 ml of the supernatant was taken for counting.
1,25-Dihydroxy vitamin D assay
The fractions of interest from the HPLC were resuspended in 600 ìÀ of dichloromethane/methanol (98 ml + 2 ml), and 50 ìÀ was taken for counting to estimate recovery. The remaining 550 ìÀ was evaporated under a dry stream of nitrogen, dissolved in 30 ìÀ of absolute ethanol, and 25 ìÀ of this solution was taken for assay. Each assay mixture consisted of 500 ìÀ of cytosol (0.9 g/1 protein), ( 3 H]l,25-dihydroxycholecalciferol (5000 counts/min in 25 ìÀ of absolute ethanol), and varying amounts of 1,25-dihydroxy vitamin D in an additional 25 ìÀ of absolute ethanol. The ethanol in all tubes except those for specific and unspecific binding was evaporated under a stream of dry nitrogen as described for the 25-hydroxy and the 24,25-dihydroxy vitamin D assays. Standard curves were constructed over a range of 9.0-1200 pg using crystalline 1,25-dihydroxycholecalciferoL After calculation of the recovery, the amount of radioactivity was corrected in the tubes containing the samples so that all tubes contained the same amount of radioactivity at the time of final assay. The assays were carried out in a shaking water bath at 25 °C for 2 h and then the tubes were immersed in an ice water bath. 250 ìÀ of ice cold, specially prepared charcoal was added to each tube. The tubes were allowed to stand for 30 min and then centrifuged at 1400 g for 15 min at 4 °C. A fraction of the supernatant (500 ìÀ) was collected and counted in a scintillation solution (Insta-Gel, Packard Instrument Company, Warrenville, USA) to a total of 10000 counts/min at 33-36% efficiency.
To the charcoal used for the 25-hydroxy and the 24,25-dihydroxy vitamin D assay, human plasma was added to give a final concentration of 50 g/1 (19) . This mixture was shaken gently for 8-12 hours at 4 °C and then centrifuged at 110f or 15 min at the same temperature. The residue was resuspended in buffer, in an ice water bath, to a final concentration of 50 g/1 charcoal. (20)). The extraction ratio with methanol is high, but the subsequent evaporation procedure, even under reduced pressure, very slow. When dichloromethane is used (9) to extract plasma, the amount of extracted lipophilic material is greatly reduced but there is a significant decrease in the recovery of [ fig. 2 ). An elution profile of labelled and unlabelled vitamin D 3 metabolites from HPLC is shown in figure 3 . The three metabolites were collected separately and assayed by competitive protein binding assays. Table 2 shows the recoveries from human plasma of radioactive labelled vitamin D 3 derivates during the separation procedure. Radioactive internal standard for each metabolite was added to 6 ml of plasma followed by methanol/methylene chloride extraction (step 1), first Sephadex LH 20 gel chromatography (elution solTab. 2. Recoveries of labelled cholecalciferol metabolites during the separation procedure according to scheme 1. The mean metabolite concentrations for a one year period were determined by assaying the pool serum of all hospitalized patients each month for 12 months. The mean values for the 12 determinations are shown in table 3, together with the corresponding plasma values of 10 pancreatectomized subjects.
Results
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.
Discussion
The assays described were used to measure the metabolites of vitamin D in plasma of normal male and female adult volunteers at different times of year. They offer an accurate and reproducible method for determination of these analytes in biological fluids.
We found a marked decrease of 25-hydroxy and 24,25-dihydroxy vitamin D in human plasma samples in April compared to those measured in October, whereas 1,25-dihydroxy vitamin D was relatively unchanged.
The average concentration of 25-hydroxy and 24,25-dihydroxy vitamin D of non-selected hospitalized patients during the whole year was between the two extreme values measured in normal human plasma, but the concentration of 1,25-dihydroxy vitamin D was higher in the hospitalized patients than in normal adults.
Our results are in good agreement with those reported in the literature. The mean value of 25-hydroxy vitamin D in October is of the same magnitude as those of Taylor (25) and Kremer (26) , but lower than that reported by Shepard (7) . We find the same for the mean value of 24,25-dihydroxy vitamin D, which is in good agreement with the data of Taylor (25) (10, 19) , and Shepard (7).
In non-selected hospitalized patients we found a mean concentration of 1,25-dihydroxy vitamin D during the whole year identical to that reported byBjorkhem (16) . He used isotope dilution mass fragmentography, the only known method which is independent of binding proteins and may therefore measure the "real" concentration of 1,25-dihydroxy vitamin D.
In patients pancreatectomized 2-6 years c prior to assay and not substituted with vitamin D, we found low levels of 25-hydroxy, 24,25-and 1,25-dihydroxy vitamin D.
In developing the four step purification procedure it was realized that Chromatographie purification of the plasma lipid abstracts was extremely important for the removal of UV absorbing compounds and contaminants which may interfere in the competitive binding assays. The contaminants that were washed out with the first 5 ml of the elution solvent of the second LH 20 column lowered a known 24,25-dihydroxy vitamin D value of 1.2 ng/tube by approximately 20% when incubated in the assay. Perhaps this contaminant is identical with the peak X reported by Shepard (7) , and this is one of the reasons why we measure 24,25-dihydroxy vitamin D by competitive binding assay and not by ÜV absorption.
It is evident that these assays will be of value not only in studying vitamin D metabolism but also as a diagnostic tool in the management of patients with disorders of calcium and phosphate metabolism.
